IZQVF Stock - Indivior PLC
Unlock GoAI Insights for IZQVF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.19B | $1.09B | $901.00M | $791.00M | $647.00M |
| Gross Profit | $957.00M | $919.00M | $750.00M | $664.00M | $550.00M |
| Gross Margin | 80.6% | 84.1% | 83.2% | 83.9% | 85.0% |
| Operating Income | $32.00M | $-156,000,000 | $-81,000,000 | $213.00M | $-156,000,000 |
| Net Income | $2.00M | $-129,000,000 | $-44,000,000 | $205.00M | $-148,000,000 |
| Net Margin | 0.2% | -11.8% | -4.9% | 25.9% | -22.9% |
| EPS | $0.02 | $0.01 | $-0.37 | $1.38 | $-1.08 |
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Visit WebsiteEarnings History & Surprises
IZQVFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Feb 16, 2023 | — | — | — | — |
Q4 2022 | Oct 27, 2022 | — | — | — | — |
Q3 2022 | Jul 28, 2022 | — | — | — | — |
Q2 2022 | Apr 28, 2022 | — | — | — | — |
Q4 2021 | Oct 28, 2021 | — | — | — | — |
Q3 2021 | Jul 29, 2021 | — | — | — | — |
Q2 2021 | Apr 29, 2021 | — | — | — | — |
Q4 2020 | Oct 29, 2020 | — | $0.10 | — | — |
Q3 2020 | Jul 30, 2020 | — | $0.02 | — | — |
Q2 2020 | May 14, 2020 | — | — | — | — |
Q1 2020 | Feb 13, 2020 | — | — | — | — |
Q4 2019 | Oct 31, 2019 | — | — | — | — |
Q3 2019 | Jul 31, 2019 | — | — | — | — |
Q2 2019 | May 2, 2019 | — | — | — | — |
Q4 2018 | Nov 1, 2018 | $0.05 | $0.12 | +140.0% | ✓ BEAT |
Q3 2018 | Jul 25, 2018 | $0.09 | $0.09 | 0.0% | = MET |
Q2 2018 | May 2, 2018 | — | — | — | — |
Q4 2017 | Nov 2, 2017 | $0.09 | $0.07 | -22.2% | ✗ MISS |
Q3 2017 | Jul 27, 2017 | $0.09 | $0.12 | +33.3% | ✓ BEAT |
Q2 2017 | May 3, 2017 | — | — | — | — |
Latest News
Frequently Asked Questions about IZQVF
What is IZQVF's current stock price?
What is the analyst price target for IZQVF?
What sector is Indivior PLC in?
What is IZQVF's market cap?
Does IZQVF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to IZQVF for comparison